It has been suggested that a subset of CRC patients (6–15%) harbor mutations in HR genes, including ATM, BRCA1/2, MRE11A, FANCC, NBN, PALB2 [54,55,58,59]. This evidence concerns the gene BRCA1 and colorectal carcinoma.